Shareholder Meeting Notices
|28/09/2018||Shareholder Circular and Notice of General Meeting to be held on 15 October 2018|
|13/08/2018||Notice of 2018 AGM|
|28/09/2017||Notice of General Meeting to be held on 16 October 2017|
|11/04/2017||Notice of Annual General Meeting 2017|
|12/10/2016||Notice of General Meeting to be held on 28 October 2016|
|11/05/2016||Notice of 2016 AGM|
|21/05/2015||Notice of 2015 AGM|
|Number of shares||61,184,135|
|Country of listing||UK / US|
|Status||AIM Listed / NASDAQ Listed|
|Index||FTSE AIM All Share / NASDAQ|
|FTSE Sector||Pharmaceutical & Biotechnology|
|Ticker||MTPH / MTP|
The percentage of 0.005p Ordinary shares not being held in public hands is 80.9%
Shares held in treasury: Nil 0.005p Ordinary shares.
There are no restrictions on the transfer of Ordinary shares in the Company.
Information correct as at 14 September 2018.
Midatech Pharma has been notified or is aware of the following holdings of more than 3% or more of the issued share capital of the Company.
|Name||Number of shares||%|
|Woodford Investment Management||12,247,629||20.0|
|Legal & General Group||9,373,017||15.3|
|Midatech Pharma Share Incentive Plan||151,802||n/a|
Information correct as at 14 September 2018
|MTP||Level III ADR||NASDAQ||1 ADR : 2 Ordinary Shares||US59564R1041||59564R104|